Circulating IL-6 is associated with disease progression in BRAFwt metastatic melanoma patients receiving anti-PD-1 therapy.

Autor: Martinović, Katarina Mirjačić, Vuletić, Ana, Miletić, Nevena Tišma, Matković, Suzana, Gavrilović, Dušica, Ninković, Aleksandra, Jurišić, Vladimir, Babović, Nada
Předmět:
Zdroj: Journal of Clinical Pathology; May2024, Vol. 77 Issue 5, p343-351, 9p
Databáze: Complementary Index